More about

Memorial Sloan Kettering Cancer Center

News
June 03, 2023
2 min read
Save

Olaparib-durvalumab regimen prolongs PFS for certain women with advanced ovarian cancer

Olaparib-durvalumab regimen prolongs PFS for certain women with advanced ovarian cancer

CHICAGO — First-line chemotherapy plus bevacizumab and durvalumab — followed by maintenance durvalumab, bevacizumab and olaparib — extended PFS compared with standard of care for women with non-BRCA-mutated advanced ovarian cancer.

News
June 02, 2023
3 min read
Save

Zanidatamab induces response in refractory HER2-positive biliary tract cancer

Zanidatamab induces response in refractory HER2-positive biliary tract cancer

CHICAGO — Zanidatamab induced durable responses among patients with previously treated HER2-amplified biliary tract cancer, according to study results presented at ASCO Annual Meeting.

News
April 24, 2023
10 min read
Save

‘A true travesty’: Despite new data and guidance, people with HIV still lack access to CAR-T

‘A true travesty’: Despite new data and guidance, people with HIV still lack access to CAR-T

Individuals living with HIV historically have been at higher risk for non-Hodgkin lymphoma.

News
April 20, 2023
2 min read
Save

Pembrolizumab active in diffuse malignant peritoneal mesothelioma

Pembrolizumab active in diffuse malignant peritoneal mesothelioma

Pembrolizumab demonstrated clinical activity among patients with diffuse malignant peritoneal mesothelioma, regardless of PD-L1 status or histology, according to data published in JAMA Network Open.

News
April 17, 2023
3 min read
Save

Patients of African ancestry less likely to qualify for colorectal cancer immunotherapy

Patients of African ancestry less likely to qualify for colorectal cancer immunotherapy

Individuals of African ancestry treated for colorectal cancer had fewer actionable genetic alterations than those of European ancestry, making them less likely to be eligible for immunotherapy, study results showed.

News
April 10, 2023
2 min read
Save

Delirium associated with higher mortality risk among critically ill patients with cancer

Delirium associated with higher mortality risk among critically ill patients with cancer

Delirium appeared associated with higher ICU and hospital mortality, as well as increased length of stay, among critically ill patients with cancer, according to data published in JCO Oncology Practice.

News
April 06, 2023
3 min read
Save

Financial toxicity worsens quality of life for partners of colorectal cancer survivors

Financial toxicity worsens quality of life for partners of colorectal cancer survivors

Partners of colorectal cancer survivors experienced long-term financial toxicity associated with worse health-related quality of life, according to results of a survey study published in JAMA Network Open.

News
April 05, 2023
2 min read
Save

BLOG: Update on double-stranded DNA viruses from Tandem Meetings

BLOG: Update on double-stranded DNA viruses from Tandem Meetings

Reactivation of double-stranded DNA viruses is an important cause of morbidity and mortality after hematopoietic stem cell transplantation.

News
March 28, 2023
3 min read
Save

Symptom tracking tool identifies post-discharge complications after debulking surgery

Symptom tracking tool identifies post-discharge complications after debulking surgery

A digital tool that tracks patient-reported symptoms helped identify post-discharge complications among women with gynecologic cancer who underwent debulking surgery, according to retrospective study results.

News
March 23, 2023
2 min read
Save

MDM2 inhibitor shows efficacy in dedifferentiated liposarcomas, other cancers

MDM2 inhibitor shows efficacy in dedifferentiated liposarcomas, other cancers

Intermittent milademetan appeared effective and mitigated dose-limiting hematologic adverse events among patients with advanced solid tumors and lymphomas, according to study results published in Journal of Clinical Oncology.

View more